Genèse Labs

12

Genèse Labs Receives CPNP Certification for Citrus Bottle

Genèse Labs Receives CPNP Certification for Citrus Bottle Genèse Labs is proud to announce that Citrus Bottle has officially received CPNP (Cosmetic Products Notification Portal) certificationin the European Union. This milestone marks an important step in strengthening the product’s regulatory foundation and expandingits availability across European markets.A Significant Regulatory AchievementThe CPNP certification confirms that Citrus Bottle meets key European cosmetic safety and com..

2024-06-30

11

Participation in AMWC Colombia 2024

First steps into the Latin American aesthetic community Medellín, Colombia — 30 May 2024 — Genèse Labs has formally entered the Latin American aesthetic-medicine community with its participation in AMWC Colombia 2024, one of the region’s principal academic congress platforms for practitioners, distributors and manufacturers.

2024-05-30

10

Citrus Bottle™ Launch and CPNP Registration

Citrus Bottle™: a next-generation slimming solution targeting adipocyte metabolism Paris, France — 22 April 2024 — Genèse Labs has launched Citrus Bottle™, a facial and body slimming solution based on adipocyte-metabolism technology, together with completion of its trademark registration and CPNP registration — extending the company’s portfolio into a new area of body contouring.

2024-04-22

9

Genèse Labs Introduces Citrus Bottle

A Modern, Precision-Formulated Solution for Body Contouring Genèse Labs is proud to announce the global launch of Citrus Bottle, a refined fat-dissolving solution created to support modern body-contouringtreatments with enhanced comfort, balanced formulation, and natural-looking results. With this release, Genèse Labs continues to expand its scientificportfolio, responding to the growing worldwide demand for safe, elegant, non-surgical shaping solutions.A Contemporary Approac..

2024-04-03

8

Genèse Labs Unveils Proluma™

A New Era in Collagen Regeneration Genèse Labs proudly announces the international launch of Proluma™, an advanced PDLLA-based collagen stimulator developed torejuvenate facial structure, restore volume, and enhance long-term skin quality. This milestone marks Genèse Labs’ strategic expansioninto regenerative aesthetics, introducing a scientifically refined solution for practitioners seeking natural and enduring results.A New Generation of Regenerative AestheticsProluma™ is ..

2024-03-30

7

Proluma™ PDLLA Launch and CE Certification

Next-generation collagen biostimulator: Proluma™ PDLLA 200 mg Paris, France — 14 February 2024 — Genèse Labs has launched Proluma™ PDLLA, an injectable collagen stimulator built on polymer technology developed at the company’s French headquarters, together with completion of the Proluma™ trademark registration.

2024-02-14

6

Genèse Labs Announces the Global Launch of RG60® Body Filler

Genèse Labs Announces the Global Launch of RG60® Body Filler Genèse Labs is proud to announce the worldwide launch of RG60®, a next-generation body filler developed to provide volume restoration,contour enhancement, and natural sculpting results for the body. As the company’s first major international product release, RG60® marksthe beginning of Genèse Labs’ growth into the global medical aesthetics industry.A New Standard in Body ContouringRG60® was created in response to the rising ..

2024-01-10

5

Launch of RG60® HA Body Filler

First in-house product RG60® sets a new standard in non-surgical body contouring Paris, France — 25 September 2023 — Genèse Labs has launched RG60® HA Body Filler, the company’s first in-house product, together with completion of the RG60™ trademark registration — an injectable dermal filler developed on French biotechnology and designed to refine body contours and correct volume without surgery.

2023-09-25

4

Partnerships Signed with KOLs and Biotech Laboratories

A collaborative development model built with clinicians and research partnersParis, France — 18 June 2023 — Genèse Labs has entered into formal partnerships with Key Opinion Leaders (KOLs) and biotechnology laboratories to develop its next generation of aesthetic products, involving clinicians directly from the formulation stage rather than only in post-launch evaluation.

2023-06-18

검색

We value your privacy